Lentiviral Mediated Production of Transgenic Mice: A Simple and Highly Efficient Method for Direct Study of Founders
October 7th, 2018
9.3K views
Here, we present a protocol to promote transgene integration and production of founder transgenic mice with high efficacy by a simple injection of a lentiviral vector in the perivitelline space of a fertilized oocyte.
Overview
This article presents a protocol for promoting transgene integration and producing founder transgenic mice with high efficacy through a simple injection of a lentiviral vector into the perivitelline space of fertilized oocytes. This method enables rapid in vivo screening of transgene effects in mice.
Key Study Components
Area of Science
- Transgenic mouse models
- Gene integration techniques
- In vivo screening methods
Background
- Transgenic animals are valuable for studying gene function.
- High efficacy in producing transgenic mice is crucial for research.
- Traditional methods can be time-consuming and less effective.
- This protocol aims to streamline the process.
Purpose of Study
- To enhance the efficiency of transgene integration.
- To facilitate gain or loss of function studies.
- To enable DNA motive mapping in transgenic mice.
Methods Used
- Injection of lentiviral vectors into the perivitelline space.
- Collection of oviducts post-euthanasia for analysis.
- Surgical techniques for accessing oviducts.
- Screening for transgene expression in newborns.
Main Results
- Over 70% of newborns showed successful transgene integration.
- The method is applicable to various mouse strains.
- Facilitates rapid screening of transgene effects.
- Supports both gain and loss of function studies.
Conclusions
- This protocol significantly improves the production of transgenic mice.
- It offers a reliable method for in vivo studies of gene function.
- The technique can be adapted for various research applications.
Frequently Asked Questions
What is the main advantage of this protocol?
The main advantage is the high efficacy of transgene integration, with over 70% success in newborns.
Can this method be applied to any mouse strain?
Yes, it can be applied to any mouse strain, including existing transgenic animals.
What are the key steps in the surgical procedure?
Key steps include making an incision in the abdominal cavity and carefully removing the oviducts.
How does this method facilitate gene function studies?
It allows for rapid in vivo screening of transgene effects, enabling gain or loss of function studies.
What is the significance of using lentiviral vectors?
Lentiviral vectors are effective for stable transgene integration in the host genome.
What outcomes can be expected from this protocol?
Researchers can expect high rates of successful transgenic offspring and efficient gene function analysis.
Executive Industry Relevance
Lentiviral-mediated transgenesis addresses a critical bottleneck in transgenic model generation by achieving founder yields above 70%, significantly improving upon traditional pronuclear injection. This high-throughput capability enables rapid in vivo screening of transgene effects, supporting early-stage target validation and functional genomics initiatives. The method’s applicability across mouse strains and high transgene penetrance (>80%) enhances its utility for mechanistic de-risking in discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables rapid interrogation of therapeutic hypotheses through high-yield founder production for gain and loss-of-function studies.
- Operational Value: Reduces animal usage and timelines by generating >50 founders per microinjection session.
- Predictive Confidence: High transgene integration and expression penetrance improve reliability of in vivo phenotypic screening.
Screening & Assay Development
- Scientific Value: Produces validated transgenic founders suitable for direct in vivo assessment of transgene regulatory elements.
- Operational Value: Standardized perivitelline injection protocol ensures reproducibility across batches and laboratories.
- Scalability: Supports screening of genomic DNA regions for enhancer/promoter activity in a physiological context.
Translational & Preclinical Research
- Translational Continuity: Founder animals allow immediate in vivo evaluation of transgene effects without breeding delays.
- Mechanistic De-risking: Enables assessment of transgene expression patterns (e.g., pancreatic bud specificity) to inform construct design.
- Preclinical Model Readiness: High integration efficiency supports generation of stable lines for downstream efficacy and safety studies.
Pipeline & Workflow Integration
This method fits within the discovery continuum from target hypothesis to lead identification by providing rapid access to functional in vivo models.
- Discovery Biology: Supports hypothesis testing via direct transgene delivery to zygotes, bypassing low-efficiency integration barriers.
- Screening: Generates quantitative outputs (e.g., eGFP expression in specific cell types) for assessing transgene activity and specificity.
- Analytics: Enables transgene copy number estimation via qPCR (e.g., average 20 integrations with Neurog3 construct) to correlate dosage with phenotype.
- Translational Research: Facilitates biomarker-aligned screening through tissue-specific promoter-driven reporters in founder animals.
- Enterprise Reuse: Protocol standardization allows reuse across projects for consistent transgenic model generation.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through high-fidelity transgene expression in relevant tissues.
- Operational Value: Standardized surgical and injection procedures enhance lab-to-lab reproducibility.
- Strategic Value: Accelerates go/no-go decisions by reducing time from construct design to in vivo data.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on rapid functional validation in mammalian systems.
Implementation Considerations
- Requires expertise in mouse embryology, microsurgery, and lentiviral vector handling under BSL-2 containment.
- Dependent on micromanipulation equipment, stereomicroscopes, and embryo culture systems (M2, M16 media).
- Necessitates cross-team standardization of injection pressure (<600 hPa) and perivitelline space targeting to ensure consistency.
- Adaptation across model systems requires optimization of viral titer and injection volume for different strain backgrounds.
- Practical limitation: transgene cargo capacity restricted to ~10 kb, limiting use for large genomic loci or complex regulatory constructs.
Biopharma FAQs
Why does transgene integration efficacy matter for target validation?
High integration efficacy (>70% of newborns) increases the likelihood of obtaining phenotypic data from founder animals, reducing the need for extensive breeding and accelerating early-stage target hypothesis testing.
How does isolating the perivitelline space as an independent variable improve discovery pipeline efficiency?
Targeted lentiviral delivery to the perivitelline space avoids cytoplasmic barriers and pronuclear membrane challenges, increasing transduction consistency and founder yield compared to pronuclear injection.
What quantitative dependent variable measurements enable assessment of transgene function in founders?
Fluorescence intensity and cell-specific expression (e.g., eGFP in Neurog3+ pancreatic bud cells) provide quantitative readouts to evaluate transgene activity and tissue specificity in vivo.
Why are replication requirements critical for cross-functional collaboration in transgenic model generation?
Standardized protocols yielding consistent founder numbers (>50 per session) and expression penetrance (>80%) allow reliable data sharing between discovery, preclinical, and translational teams.
What statistical analysis capabilities are required before implementing lentiviral transgenesis in a discovery workflow?
Ability to quantify transgene copy number via qPCR and correlate with phenotypic expression levels supports data-driven decisions on construct efficacy and dosage effects.
Chapters in this video
0:04
Title
0:40
Collecting Fertilized Eggs from Superovulated Mice
2:49
Preparation of Injection Pipette Containing the Lentiviral Vector, Micro-Injection
5:04
Transferring Embryos into B6CBAF1/JRj Pseudopregnant Females
8:10
Results: Various Tested Constructs
9:28
Conclusion
